“…The environment can influence both the initiation and expression of behavioral sensitization. Thus, animals repeatedly exposed to drugs such as cocaine, amphetamine, or morphine during the initiation phase expressed more robust sensitization when re-exposed to drug in the same environment (paired) as previous drug exposure during the expression phase, compared with animals tested in an environment that differed (unpaired) from that used during the initiation phase Anagnostaras and Robinson, 1996;Wang and Hsiao, 2003;Mattson et al, 2008;Vezina and Leyton, 2009). Behavioral sensitization in the paired environment is commonly referred to as context-dependent sensitization as opposed to con-1 Abbreviations: AMPA, ␣-amino-3-hydroxyl-5-methyl-4-isoxazolepropionate; CNQX, 6-cyano-7-nitroquinoxaline-2,3-dione; CPP, conditioned place preference; CRF, corticotropin-releasing factor; GluR, glutamate receptor; JNJ16259685, (3,4-dihydro-2H-pyrano[2,3-b] quinolin-7-yl)-(cis-4-methoxycyclohexyl)-methanone; LDT, laterodorsal tegmentum; LTP, long-term potentiation; LY341495, 2-[(1S,2S)-2-carboxycyclopropyl]-3-(9H-xanthen-9-yl)-D-alanine; LY379268, (1R,4R,5S,6R)-4-amino-2-oxabicyclo[3.1.0]hexane-4,6-dicarboxylic acid; mGluR, metabotropic glutamate receptor; mPFC, medial prefrontal cortex; NMDA, N-methyl-D-aspartate; PPT, pedunculopontine tegmentum; PVN, paraventricular nucleus; SCH23390, (R)-(ϩ)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine; SKF 81297, (Ϯ)-6-chloro-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrobromide; SKF38393, 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; SKF82958, (Ϯ)-6-chloro-7,8-dihydroxy-3-allyl-1-phenyl-2,3,4,5-tetra-hydro-1H-benzazepine; VTA, ventral tegmental area.…”